Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01149876 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT01149876: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT01149876 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01149876, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.
Primary Outcome
Primary outcome measure will be change in hyperpigmentation of baseline compared to week 16. Hyperpigmentation will be measured clinically using a 0-6 scale where 0 is no hyperpigmentation and 6 is very severe hyperpigmentation.
Interventions
- OTHER Nu Skin Product
- OTHER Cosmetic instrument
- DRUG Tretinoin cream 0.05
- OTHER CeraVe moisturizer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
What the finished NCT01149876 record still lists
NCT01149876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 4 interventions - of which Nu Skin Product is the first listed.
NCT01149876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01149876 about?
NCT01149876 is a clinical study titled "Study to Evaluate the Effect of a Nu Skin Product and Device for Brown Spots". The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.
What is the current status of trial NCT01149876?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2010-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01149876?
The interventions under investigation include: Nu Skin Product (OTHER), Cosmetic instrument (OTHER), Tretinoin cream 0.05 (DRUG), CeraVe moisturizer (OTHER).
Who is sponsoring clinical trial NCT01149876?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01149876's enrollment target sits among peer trials
80 946th of 2000 higher than 1,021 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia